Copyright © {{ year }} Farmak International. All Rights Reserved.
\n \n \n\n Amb el suport de:\n
\n\n \n\n\n \n scroll down\n
\n\n ICM Farmak S.L. ha sigut beneficiària de la línia d’ajuts\n a inversions empresarials d’alt impacte de creació d’ocupació 2023, impulsada per l’agència per a\n la competitivitat de l’empresa (https://www.accio.gencat.cat), per a la Creació\n d’ocupació de personal per una nova planta productiva i de R+D per a productes farmacèutics a Catalunya.\n
\n\n Pressupost: 1.455.190,00€\n
\n\n Ajut: 437.607,00€\n
\n\n\n ICM Farmak S.L. has been a beneficiary of the line of grants for high-impact business investments in job creation 2023,\n promoted by the Agency for the Business Competitiveness (https://www.accio.gencat.cat) for the creation\n of new employment opportunities for personnel at a new production plant and R&D for pharmaceutical\n products in Catalonia.\n
\n\n Budget: 1.455.190,00€\n
\n\n Grant: 437.607,00€\n
\n\n ICM Farmak S.L. ha sigut beneficiària de la línia d’ajuts a inversions empresarials d’alt impacte en actius fixes 2023, \n impulsada per l’agència per a la competitivitat de l’empresa (https://www.accio.gencat.cat), per a la Creació\n d’una nova planta productiva i de R+D per a productes farmacèutics a Catalunya.\n
\n\n Inversió: 6.252.320,00€\n
\n\n Ajut: 500.000,00€\n
\n\n\n ICM Farmak S.L. has been a beneficiary of the line of grants for high-impact business investments in fixed assets 2023, \n promoted by the Agency for the Business Competitiveness (https://www.accio.gencat.cat),\n for the creation of a new production plant and R&D for pharmaceutical products in Catalonia.\n
\n\n Budget: 6.252.320,00€\n
\n\n Grant: 500.000,00€\n
\nProviding easy access to effective, high-quality medicines to contribute to the health of society
\nBecome a strong global partner in the specialty care sector while maintaining high standards of\n quality, innovation, and social responsibility
\nEU-CDMO
\nMANUFACTURING OF STERILE MEDICINES IN VIALS AND SYRINGES
\nRESEARCH & DEVELOPMENT\n CENTER
\nSHARING OF KNOWLEDGE & TECHNOLOGICAL PROCESS IMPROVEMENTS
\nEU-IMPORTER
\nIMPORTING OF FDF COMING FROM OTHER COUNTRIES
\nActing as manufacturing facility under the signed TQA with other MAHs\n through B2B model
\nSterile production of liquid medicines in the form of\n solutions and suspensions according to annex 1 of EU-GMP
\nFilling of syringes and vials as a pharmaceutical form for sales as in\n bulk or FDF
\nAseptic Vials & Syringes filling Site
\nPharmaceutical development for high-tech products to increase the\n Farmak company's portfolio
\n\n Scientific advice\n on preparation/ update of M3 dossiers development\n
\n\n Use of laboratories for the purposes of\n analytical and microbiological control\n in accordance with EU and US directives\n
\nR&D center + Microbiology control + QC Lab
\n\n Importing of Final Dosage Forms\n from other countries\n
\n\n Quality Control\n on imported batches\n according to the Ph. Eur. and Marketing Authorization dossier\n
\n\n Batch release\n for distribution of products in EU countries\n
\nWe are looking forward to hearing from you and thank you for your\n interest in Farmak International
\n\n ICM Farmak S.L.U.\n
Avenida de Arraona, 119-123\n
08210 Barberà del Vallès, Barcelona, Spain
Country
\nAseptic Vials & Syringes filling Site
\nR&D center + Microbiology control + QC Lab
\n\n ICM Farmak S.L.U.
\n Avenida de Arraona, 119-123
\n 08210 Barberà del Vallès, Barcelona, Spain\n
\n Amb el suport de:\n
\n\n \n\n